UK markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
386.00+7.00 (+1.85%)
At close: 03:57PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts2156
Avg. Estimate4.041.815.4612.89
Low estimate3.311.814.2810.4
High estimate4.761.817.0114.84
Year ago EPS2.061.576.2415.46
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts3167
Avg. Estimate707.22M512.87M2.07B2.41B
Low estimate635.51M512.87M2.01B2.03B
High estimate749.52M512.87M2.12B2.56B
Year ago sales358.77M290.28M1.16B2.07B
Sales growth (year/est)97.10%76.70%78.50%16.10%
Earnings history29/09/202130/12/202129/06/202229/09/2022
Est. EPS1.271.442.032.75
Actual EPS2.061.573.85.61
Difference0.790.131.772.86
Surprise %62.20%9.00%87.20%104.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate4.041.815.4612.89
7 days ago4.041.7915.4512.89
30 days ago3.711.7414.9513.03
60 days ago3.71014.9412.65
90 days ago3.809.811.59
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesGNMSFIndustrySector(s)S&P 500
Current qtr.96.10%N/AN/AN/A
Next qtr.14.60%N/AN/AN/A
Current year147.80%N/AN/AN/A
Next year-16.60%N/AN/AN/A
Next 5 years (per annum)4.71%N/AN/AN/A
Past 5 years (per annum)40.60%N/AN/AN/A